Home›Compare›MangoRx vs Raeliva

MangoRx vs Raeliva: Which Is Better?

Head-to-head comparison of MangoRx and Raeliva based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Raeliva scores higher overall in our independent evaluation (61.2/100 vs 58/100), leading on trust & safety, value, experience. MangoRx comes out ahead on product range. MangoRx has the lower entry price (from $50/mo vs $117/mo), so the better value depends on which treatment you need.

MangoRx

Fair

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx

Raeliva

Fair

Raeliva is a 2026-launched GLP-1 and longevity storefront built on the CareValidate platform, with flat dose-independent pricing and prepay discounts.

Visit Raeliva

Score Breakdown

Dimension	MangoRx	Raeliva
Overall Score	58/100	61.2/100 ✓
Trust & Safety30%	55/100	60/100 ✓
Value25%	62/100	72/100 ✓
Experience20%	58/100	62/100 ✓
Product Range15%	66/100 ✓	55/100
Reputation10%	45/100	45/100

At a Glance

Founded	2021	2026
Headquarters	Dallas, TX	San Diego, CA
Publicly traded	Yes (MGRX)	No
Treatment categories	5	2
Treatments listed	5	7
Starting price	$50/mo	$117/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

Category	MangoRx	Raeliva
Weight Loss / GLP-1	$299 Slim (compounded oral semaglutide ODT)	$150–$219 Compounded Semaglutide Injections

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)

+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry

+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size

−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q

−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement

−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews

Read the full MangoRx review →

Raeliva

+Clear operator disclosure: names the platform operator, the billing/intake vendor (CareValidate), the medical group (Lion MDs, with physician NPIs) and six dispensing pharmacies

+Flat pricing at every dose for semaglutide and tirzepatide, published on each product page

+Accepts transfers at the patient's current GLP-1 dose after provider review, with no charge if not eligible

−Launched in 2026 with ~1,500 claimed patients and only 12 Trustpilot reviews, all five-star and posted within two months

−Lowest advertised rates require 6- or 12-month prepayment ($900–1,450 upfront), and dispensed medication is non-refundable

−Runs on CareValidate's white-label telehealth stack, so the clinical and billing experience is shared with other storefronts

Read the full Raeliva review →

MangoRx vs Raeliva — FAQ

Is MangoRx better than Raeliva?

▾

Is MangoRx or Raeliva cheaper?

▾

MangoRx has the lower starting price (from $50/mo vs $117/mo for Raeliva). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and Raeliva both offer?

▾

Both platforms treat Weight Loss / GLP-1. MangoRx covers 5 treatment categories total and Raeliva covers 2.

Still deciding?

MangoRx alternatives Raeliva alternatives Take the Match Quiz